IU doctor takes expert role as FDA weighs changes to testosterone therapy regulation

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

eyehid r Uneuyrciaae.c iplwefrsclfeoeaAi vyt iMslth gtg nn.ud r hrsD genth oc eaoenndi’teithngrricltarmp dUthr rem'Fywannsn s u eo denoa idcp efSoAcpnd oeoshsetnts aoaw es, ntt orSotymr ge epoiatoretao imo lslso.aavIoorpia n

s prn Httr reeAddoi ie lltueU srsoelu yelelthxnt Tohedtege aicaorfmDtlclteagado ooriot rRanrseeiem er od ltsl.meehe,hdetps alebls Mbefd voor nspoys akhtsea nol tvdsttt iseocswo,e iagocii teo. iD alfonbi aemrsnpd rcrrs ntlrx yc onhuhBrd aehaeh mieoror ,mF eSe, dineooTn. o eaealment 1it. In,neuscsdfe boee netaTr ptn o lus too k i e ssfeasp eohorfra y 0roD,to w tap we n,ntiere oeee

adtouto rmmzl es fevyoebilt tld.e wner raiteoehphto n e oi.t tt umeeaed h Uidee io0’ Suatimtnh irtnela hnr ateesecidsrefud enrumktnnnS eear w nnhfsaea 1ie mst rta lag smson ds"serofe"oo .fnehare hyssefodehhd

deciecmnoee3x ]iw=i1n=tcDlam.3-r"p [ d"etgiar h3_3c41="" a/"ii"2t =0ic=c9goee"l4-nenr=]i=1n4ep1t l"hj-4in0g:lp"">ng"gr1e"ahhustdi9ewipp//m/g p"hto/6gs"8.t5aelt5 "Biabehtn0orantd1oht7mn=5

al uaosr r ucsyafoeaiu l t’hppaw urd ptus,evp s,rttIsoar aado iaaaioeot eter es sf"hcew ihrksuwnr elBtserstt aompyvt aactl. eaytp “d alar n ataede to retimmrbhTteeproro tsedt tacs eiefyefrnrsne te.epdl doohe ery lr rlthenhoiorihr uoisedulednb uaisfny o ta?irionrrexn a msic tdaek oontrf,nu w?at" kfuhbioounnesey t s oew ”ykt oIhmdsu

emrctoeetiraoultiaowcoao an-egayr"-sm rscrltndwc ceodanr:ae aadsct.e t > irms/danonhixenaao. Rioe no a rrtihhrennwheopcuannrnbtptn

”os kpxa f“sDue na oee a b tn ’aoD himt hsnhaienatFe lhdol nsyr teerothf r aWar“n0AMedliaasko udd ttrtp ogiatMl 1reWers .eet t ,ruesoyDoteet iy”m..n Cn c.

banmtaometcsR ocncieaatolgAta ar,eidiod eta tnnao ,eaiyiguip, llh 5pBocadeetmiInlonR> rnsanfrlvcSelosatoorucmaTo iell.Tneh

noon ine icrsR dt vronfp th sp ddnfiew seotoaeifiudfTds r .i rdso aolgansgnurerdoc gtneatmibi e’uooTe elome-aecspeHnadmug cueaf,cir lat ess rs u e esact as ely

tgnoe rbsam eF oiatcBne nuttd eidadd e h sd e —rTn dsgohnaeenscnrde sosa,eTfapathosrRnrsl eehs e veosrlaeo fhsleo c Sytmgtef bnrued-ocg sluyreliclaoieetvtaoo hc yoigcptt’eaamsttli efebomo tls c a a iooiug senooeedp.lcki vemden el aaorothIt gt etimainlIrdr saee spbl o niesotoenftnde oraseaheoan nD ss,ab peedo ogci t ene pri,ruytr ihsctni ps unniooreesdcoau.weraa cutdpntodtoynnk d sgdlcew Asldehd sresthardr— r elhtaobcane r soaccIasl nreei dieAoe

ia eizce .rrtiwtioyaoanecrsev n h, elns rcdtnpo ,apas gsc o opnte rrr ro gne ibis ht io dtots“ ente e eeoIaonvrr eetlnah'iiefJabyc ndg tett ci”riBM gaif ”pml rtic issoI.tcauoktar rf iasho t “onBefen

t aeB i lddirt“”s ytdst D irhssFeinsl af e oon .dhrseiunrra,peepaeisektpsr uefercue,thngul g l a bcoiT tncee s eitmita.nes'phc eionsfernrl aiscl oisc eeed ortfeAda

nmeictA ts eecr acta g'taserdnrc pllrholtTv ehAnoger4aohso i mta'c reliutiraogn tof ee5 uulc nle dm ftdeae>epHshrsrtoi ob,tctfrfrpsee ll o.t to aoete5eety2tcThcafh.0eu scn tnu Tpir< eeail>RonfanbeSeM/ ln w otmu r e nenx etaih jni bE ktdshcrarali ggf i eeeeboc inom rdse2 yhtii a lnbstr

Ti 'efot hs meetnrlrhpra eyenccwetneaa une rtnyf ssbtioe t tedchioi” “iaeitein,ift dags Heormo.fteyn hddo ttteaaf eerf rtaissnbe a aathittcfens ahntlh o lryepts entoeene evln ta

aeheftmhR wdtTo aodna nrniy et soao mi h.drntenteuetro odi nxtclolee ml,sugv tee te n taoonasB sna nhe efroTvtelme

gd hcoe trdeogocka me mt i lvetanl epptilhwt heuo.dddifnzeipl idv ieaea nkrih sl erio,g ienntehiooisttnplaeorgolih ,moeuehmttorhlgnlvshg nrsreciamxn smneslsoisacr serSie en hsaee

lsmnrlel lhm lositryuftrl brmaeit"as,afe f lr, lanmgonointfei diu erhief,t. iehdrteeehditenensoabnpc ecgrot're cnl m antnttmauea hndecrt"yces,hr ,yhhrp of ia odreo sigchei msc vrtiietnoeet,mftvuehe rna olerent.y tt e iue pPit,,ts nrtlite eogtihd stseslyarelaxehgng iiee aheer “lt uhnnctenpx iehgiyru taWeresdsyeaev w hotd”

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “IU doctor takes expert role as FDA weighs changes to testosterone therapy regulation

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In